<table border="0" cellpadding="0" cellspacing="0" id="SPLSERV-59F13E1A-31E7-A720-6EB2-C0F280BB9CFD" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 18: The Effect of Quetiapine on the Pharmacokinetics of Other Drugs</caption>
<tbody>
<tr>
<td rowspan="2" valign="top">
<content stylecode="bold">Coadministered drug</content>
</td>
<td colspan="2" stylecode="Lrule" valign="top">
<content stylecode="bold">Dose schedules</content>
</td>
<td rowspan="2" stylecode="Lrule" valign="top">
<content stylecode="bold">Effect on other drugs pharmacokinetics</content>
</td>
</tr>
<tr>
<td stylecode="Lrule Toprule" valign="top">
<content stylecode="bold">Coadministered drug</content>
</td>
<td stylecode="Lrule Toprule" valign="top">
<content stylecode="bold">Quetiapine</content>
</td>
</tr>
<tr>
<td stylecode="Toprule" valign="top">Lorazepam</td>
<td stylecode="Lrule Toprule" valign="top">2 mg, single dose</td>
<td stylecode="Lrule Toprule" valign="top">250 mg three times daily</td>
<td stylecode="Lrule Toprule" valign="top">Oral clearance of lorazepam reduced by 20%</td>
</tr>
<tr>
<td stylecode="Toprule" valign="top">Divalproex</td>
<td stylecode="Lrule Toprule" valign="top">500 mg twice daily</td>
<td stylecode="Lrule Toprule" valign="top">150 mg twice daily</td>
<td stylecode="Lrule Toprule" valign="top">C<sub>max</sub> and AUC of free valproic acid at<br/>steady-state was decreased by 10-12%</td>
</tr>
<tr>
<td stylecode="Toprule" valign="top">Lithium</td>
<td stylecode="Lrule Toprule" valign="top">Up to 2400 mg/day given in twice daily doses</td>
<td stylecode="Lrule Toprule" valign="top">250 mg three times daily</td>
<td stylecode="Lrule Toprule" valign="top">No effect on steady-state pharmacokinetics of lithium</td>
</tr>
<tr>
<td stylecode="Toprule" valign="top">Antipyrine</td>
<td stylecode="Lrule Toprule" valign="top">1 g, single dose</td>
<td stylecode="Lrule Toprule" valign="top">250 mg three times daily</td>
<td stylecode="Lrule Toprule" valign="top">No effect on clearance of antipyrine or urinary recovery of its metabolites</td>
</tr>
</tbody>
</table>